GC Genome Corporation (KOSDAQ:340450)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,570.00
+90.00 (1.20%)
Apr 14, 2026, 2:25 PM KST
Market Cap176.91B
Revenue (ttm)31.53B +21.8%
Net Income4.04B
EPS185.00
Shares Out23.65M
PE Ratio40.43
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume83,111
Average Volume189,862
Open7,510.00
Previous Close7,480.00
Day's Range7,510.00 - 7,750.00
52-Week Range6,200.00 - 15,180.00
Betan/a
RSI47.87
Earnings DateApr 10, 2026

About GC Genome

GC Genome Corporation operates as a clinical genome analysis company in South Korea. It offers hereditary cancer, tissue and liquid biopsy genetic, blood cancer, and homologous recombination deficiency tests under the Green Plan names; Guardant360, a blood genetic profiling test; Guardant Reveal, a liquid biopsy microscopic residual disease detection and recurrence monitoring test; and genetic rare disease testing services for chromosomal microarray, targeted exome sequencing, whole exome sequencing, and diagnostic genome sequencing. The compan... [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 340450
Full Company Profile

Financial Performance

Financial Statements